🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kolhāpur
Clinical trial register · India

Clinical Trials in Kolhāpur

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1125 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:16 UTC
1125
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
221
Lead sponsors
across recruiting studies
Top sites
New Delhi 334 Mumbai 259 Hyderabad 238 Bangalore 194 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novo Nordisk A/S4 Eli Lilly and Company3 AstraZeneca2 Kolhapur Cancer Centre - Cancer Centers of America2 Novartis Pharmaceuticals2
Site location
New Delhi334 Mumbai259 Hyderabad238 Bangalore194 Pune189
All 273 locations
Target enrolment
to
22 of 1125 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
NCT07668401Obesity, Overweight
Novo Nordisk A/S
Phase 3
400
Surat, Vadodara, Hubbali, Kozhikode, Indore, Kohlapur, Kolhāpur, Mumbai
2027-01-07
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461Type 2 Diabetes
Boehringer Ingelheim
Phase 3
600
Ahmedabad, Bhubaneswar, Cuttack, Hyderabad, Afzalgunj, Kolhāpur, Lucknow, Nagpur, Nashik
2026-08-24
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
NCT07282613Diabetes Mellitus, Type 2
Novo Nordisk A/S
Phase 3
80
Guntur, Surat, Bangalore, New Delhi, Delhi, Kanpur, Kolkata, Kolhāpur
2026-08-04
Recruiting
Study Comparing Limited and Extensive Neck Surgery in Oral Cancer Patients With Neck Spread
NCT07717307Oral Cavity Squamous Cell Carcinoma
Kolhapur Cancer Centre - Cancer Centers of America
Not applicable
80
Kolhāpur
2026-08-01
Recruiting
Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread
NCT07726199Oral Squamous Cell Carcinoma (OSCC)
Kolhapur Cancer Centre - Cancer Centers of America
Not applicable
267
Kolhāpur
2026-04-22
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190Overweight, Obesity
Eli Lilly and Company
Phase 3
900
Allahābād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mumbai
2026-02-10
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507Schizophrenia
Eli Lilly and Company
Phase 2
450
Aurangabad, Bhopal, Chennai, Dehradun, Dharwad, Karjat, Kolhāpur, Lucknow
2026-02-10
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
NCT07282743Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
Phase 2
285
Guntur, Bangalore, Kozhikode, Trivandrum, Kolhāpur, Mumbai, Pune, New Delhi
2026-01-20
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285Overweight, Obesity
Novo Nordisk A/S
Phase 3
460
Guntur, Surat, Bangalore, New Delhi, Delhi, Kanpur, Kolkata, Kolhāpur
2026-01-08
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
NCT07221253Biliary Tract Cancer
AstraZeneca
Phase 3
1,100
Delhi, Hyderabad, Kolhāpur, Kolkata, Mumbai, Nashik, Surat
2025-12-04
Active, closed
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
NCT06981078Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.
Phase 2
666
Hyderabad, Nellore, Vijayawada, Gurgaon, Rohtak, Kolhāpur, Nagpur, New Delhi
2025-07-02
Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06417814Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 3
744
Amravati, Bhubaneswar, Hyderabad, Kolhāpur, Mumbai, Mysuru, Namakkal, Pune
2024-10-04
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
550
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi
2024-05-21
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
1,264
Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhāpur
2023-12-21
Active, closed
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc.
Phase 2
37
Ahmedabad, Kannur, Visakhapatnam, Kolhāpur, Dehradun, Madurai, Hyderabad, Kolkata
2023-12-09
Active, closed
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
NCT05827016Multiple Myeloma
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhāpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05850689Major Depressive Disorder
Intra-Cellular Therapies, Inc.
Phase 3
470
Ahmedabad, Ajmer, Bārāmati, Bikaner, Chandigarh, Guwahati, Kolhāpur, Nagpur
2023-05-02
Active, closed
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
NCT05624749Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
288
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi, Dehradun
2023-04-21
Active, closed
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S
Phase 3
153
Guwahati, Surat, Kolhāpur, Mumbai, Pune, Cuttack, Jaipur, Noida
2022-03-24
Active, closed
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
NCT04961996Early Breast Cancer
Hoffmann-La Roche
Phase 3
4,170
Vijayawada, Patna, Ahmedabad, Surat, Vadodara, Belagavi, Amravati, Kolhāpur
2021-08-27
Recruiting
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer
NCT02992574Breastcancer
Tata Memorial Centre
Not applicable
1,022
Chandigarh, Kolhāpur, Mumbai, Delhi, New Delhi, Jaipur
2016-05-27
Active, closed
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer
NCT01916317Operable Breast Cancer
Tata Memorial Hospital
Phase 3
1,600
Guwahati, Ahmedabad, Kannur, Kolhāpur, Mumbai, Pune, Sangli, Shillong
2011-12-12
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-india/city/kolh-pur

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.